___

• Al-Sweih, N., Jamal, M., Kurdia, M., Abduljabar, R., Rotimi, V. 2005. Antibiotic susceptibility profile of group B streptococcus (streptococ- cusagalactiae ) at the Maternity Hospital, Kuwait. Med. Princ. Pract.14, 260–263.
• Betriu, C., Culebras, E., Gomez, M., Rodríguez-Avial, I., Sanchez, B.A., Agreda, M.C., Picazo, J.J. 2003. Erythromycin and clindamycin resistance and telithromycin susceptibility in streptococcus agalactiae. Antimicrob. Agents Ch. 47, 1112–1114.
• De Mouy, D., Cavallo, J.D., Leclercq, R., Fabre, R. The Aforcopı-Bıo Network. 2001. Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical ısolates of streptococcus agalactiae: french multicenter study. Antimicrob. Agents Ch. 45, 2400–2402.
• Elbaradie, S.M.Y., Mahmoud, M., Farid, M. 2009. Maternal and neonatal screening for group B streptococci by SCPB gene based PCR: a pre liminary study. Indian J. Med. Microbi. 27, 17-21.
• Figueira-Coelho, J., Ramirez, M., Salgado, M.J., Melo-Cristino, J. 2004. Streptococcus agalactiae in a large portuguese teaching hospital: anti- microbial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant ısolates. Microb. Drug Resist. 10, 31-36.
• Fluegge, K., Supper, S., Siedler, A., Berner, R. 2004. Antibiotic susceptibility in neonatal invasive isolates of streptococcus agalactiae in a 2-year nationwide surveillance study in Germany. Antimicrob. Agents Ch. 48, 4444–4446.
• Karakus, M., Karaca, D.Y., Günçiner, Ş. 2007. Colonization and antimicrobial resistance patern of group B streptococcus in pregnant women. Ege J. Med. 46, 151 -154.
• Kawamura, Y., Fujiwara, H., Mishima, N., Tanaka, Y., Tanimoto, A., Ikawa, S., Itoh Y., Ezaki, T. 2003. First streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. Antimicrob. Agents Ch. 47, 3605-3609
• Kraśnianin, E., Skret-Magierło, J., Witalis, J., Barnaś, E., Kluz, T., Kozieł, A., Skret, A. 2009. The incidence of streptococcus group b in 100 parturient women and the transmission of pathogens to the newborn. Ginekol. Pol. 80, 285-289.
• Kulkarni, A.A., Pawar, S.G., Dharmadhikari, C.A., Kulkarni, R.D. 2001. Colonization of pregnant women and their newborn infants with group-B streptococci. Indian J. Med. Microbi. 19, 1-4.
• Money, D.M., Dobson, S. 2004. The prevention of early-onset neonatal group B streptococcal disease. J. Obstet. Gynaecol. Can. 26, 826–832.
• Monique, T.S., Jan, K., Louis, K., Bakkers, J., Melchers, W., Spanjaard, L., Wannet, W.J., Hoogkamp-Korstanje, M.A. 2006. Serotypes, geno types and antibiotic susceptibility profiles of group B streptococci causing neonatal sepsis and meningitisbefore and after introduction of antibiotic prophylaxis. Pediatr. Infect. Dis. J. 25, 945-948.
• Moyo, S.R., Maeland, J.A., Bergh, K. 2002. Typing of human isolates of streptococcus agalactiae (group B streptococcus, gbs) strains from Zimbabwe. J. Med. Microbiol. 51, 595–600.
• Ölçü, M., Eşel, D. 2007. Antibiotic susceptibilities of clinical streptococcus agalactiae isolates. J. Health Sci. 16, 23-27. 3 Dilek et al.
• Schrag, S.J., Phil, D., Zywicki, S. Farley, M.M., Reingold, A.L., Harrison, L.H., Lefkowitz, L.B., Hadler, J.L., Danila, R., Cieslak, P.R., Schuchat, A. 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342, 15-20.
• Topkaya, A., Küçükercan, M., Oğuzoğlu, N., Ünal, N., Narin, K. 2003. Antibiotic susceptibilities of group B streptococci isolated from vaginal and rectal colonization in pregnant women. J. Turk. Microbi. Society. 33, 242-245.
• Tünger, A., Çavuşoğlu, C., Korkmaz, M. 2005. Group B streptococcus. Asya Microbi. 94-96.
• Quiroga, M., Pegels, E., Oviedo, P., Pereyra, E., Vergara, M. 2008. Antibiotic susceptibility patterns and prevalence of group B streptococcus isolated from pregnant women in misiones, Argentina. Brazilian J. Microbi. 39, 245-25.